Bordet Scientific Publications

Bordet Scientific Publications

  • Reply to Bourgeois P.

  • Auteurs Pop CF, Veys I, Liberale G
  • Auteurs (entité) LIBERALE GABRIEL
  • Revue Breast Cancer Res Treat
  • Date de publication 2024-11
Reply to Bourgeois P.
  • Exploring the driver events of eccrine poromas and porocarcinomas: A retrospective, cross-institutional study of 54 cases.

  • Auteurs Arends MJ, Del Castillo Velasco-Herrera M, Cheema S, Wong K, Boccacino JM, Vermes I, Roberts K, Anderson E, van der Horst MPJ, de Saint Aubain N, Alomari AK, Monteagudo C, Billings SD, Frew D, Clarke E, Merchant W, Rajan N, Ferguson P, Mogler C, Ferreira I, Brenn T, van der Weyden L, J Adams D
  • Auteurs (entité) DE SAINT AUBAIN NICOLAS
  • Revue Br J Dermatol
  • Date de publication 2024-11
Exploring the driver events of eccrine poromas and porocarcinomas: A retrospective, cross-institutional study of 54 cases.
  • Extending Our Understanding of the Social Determinants of Physical Activity and Sedentary Behaviors in Families: A Systems Mapping Approach.

  • Auteurs Rhodes RE, Banik A, Szczuka Z, Aulbach MB, DeSmet A, Durand H, Gatting L, Green J, Hillison EZ, Masaryk R, Radtke T, Rigby BP, Schenkel K, Warner LM, Jones CM, Luszczynska A
  • Auteurs (entité) DESMET ANTOINE
  • Revue J Phys Act Health
  • Date de publication 2024-11
Extending Our Understanding of the Social Determinants of Physical Activity and Sedentary Behaviors in Families: A Systems Mapping Approach.
  • Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines.

  • Auteurs Rossi C, Manson G, Marouf A, Cabannes-Hamy A, Nicolas-Virelizier E, Maerevoet M, Alcantara M, Molina L, Ceraulo A, Poirée M, Galtier J, Diop N, Delette C, Segot A, Dubois S, Waultier A, Bernard S, Noël R, Guidez S, Kohn M, Bailly S, Moatti H, Touati M, Renaud L, Kanoun S, Cottereau AS, Kirova Y, Peignaux K, Dourthe ME, Simonin M, Leblanc T, Quéro L, Krzisch D, Duléry R, Grenier A, Gastinne T, Casasnovas O, Gallamini A, André M, Morschhauser F, Deau B, Fornecker LM, Ghesquières H
  • Auteurs (entité) MAEREVOET MARIE
  • Revue Eur J Cancer
  • Date de publication 2024-10
Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines.
  • Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial.

  • Auteurs De Jaeghere EA, Hamerlinck H, Tuyaerts S, Lippens L, Van Nuffel AMT, Baiden-Amissah R, Vuylsteke P, Henry S, Trinh XB, van Dam PA, Aspeslagh S, De Caluwé A, Naert E, Lambrechts D, Hendrix A, De Wever O, Van de Vijver KK, Amant F, Vandecasteele K, Verhasselt B, Denys HG
  • Auteurs (entité) DE CALUWE ALEX
  • Revue Gynecol Oncol
  • Date de publication 2024-11
Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial.
  • Impact of the radiological morphology of the mesopancreas on the outcome after pancreatoduodenectomy for pancreatic ductal adenocarcinoma: retrospective study.

  • Auteurs Navez J, Pezzullo M, Bouchart C, Arsenijevic T, Demetter P, Closset J, Azurmendi Senar O, Racu ML, D'Haene N, Devière J, Verset L, Bali MA, van Laethem JL
  • Auteurs (entité) DEMETTER PIETER
  • Revue BJS Open
  • Date de publication 2024-10
Impact of the radiological morphology of the mesopancreas on the outcome after pancreatoduodenectomy for pancreatic ductal adenocarcinoma: retrospective study.
  • Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial.

  • Auteurs Classe JM, Meeus P, Hudry D, Wernert R, Quenet F, Marchal F, Houvenaeghel G, Bats AS, Lecuru F, Ferron G, Brigand C, Berton D, Gladieff L, Joly F, Ray-Coquard I, Durand-Fontanier S, Liberale G, Pocard M, Georgeac C, Gouy S, Guilloit JM, Guyon F, Costan C, Rousselet JM, de Guerké L, Bakrin N, Brument E, Martin E, Asselain B, Campion L, Glehen O
  • Auteurs (entité) LIBERALE GABRIEL
  • Revue Lancet Oncol
  • Date de publication 2024-12
Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial.
  • Assessment of the American College of Surgeons Surgical Risk Calculator (ACS-SRC) for Prediction of Early Postoperative Complications in Patients Undergoing Cytoreductive Surgery for Ovarian Peritoneal Carcinomatosis.

  • Auteurs Kabeya C, Khaled C, Polastro L, Moreau M, Bucella D, Fastrez M, Liberale G
  • Auteurs (entité) POLASTRO LAURA
  • Revue Curr Oncol
  • Date de publication 2024-12
Assessment of the American College of Surgeons Surgical Risk Calculator (ACS-SRC) for Prediction of Early Postoperative Complications in Patients Undergoing Cytoreductive Surgery for Ovarian Peritoneal Carcinomatosis.
  • Assessment of the American College of Surgeons Surgical Risk Calculator (ACS-SRC) for Prediction of Early Postoperative Complications in Patients Undergoing Cytoreductive Surgery for Ovarian Peritoneal Carcinomatosis.

  • Auteurs Kabeya C, Khaled C, Polastro L, Moreau M, Bucella D, Fastrez M, Liberale G
  • Auteurs (entité) KABEYA CEDRIC
  • Revue Curr Oncol
  • Date de publication 2024-12
Assessment of the American College of Surgeons Surgical Risk Calculator (ACS-SRC) for Prediction of Early Postoperative Complications in Patients Undergoing Cytoreductive Surgery for Ovarian Peritoneal Carcinomatosis.
Erasme hospital

Erasmus Hospital

View all of Erasmus's scientific publications

Huderf hospital

Queen Fabiola Children's Hospital

View all scientific publications from the Queen Fabiola Children's Hospital

Bordet hospital

Jules Bordet Institute

View all of Jules Bordet's scientific publications